Neuralink brain chip trials launch in Britain for paralyzed patients

Neuralink, Elon Musk’s brain-implant company, has initiated its first European clinical trial in the UK, aiming to test its brain-computer interface (BCI) technology on seven patients with severe paralysis caused by spinal cord injuries or neurological conditions like ALS. The trial, conducted in partnership with University College London Hospitals NHS Foundation Trust and Newcastle upon Tyne Hospitals, involves implanting Neuralink’s N1 chip under the skull to enable patients to control digital devices such as smartphones and tablets using only their thoughts. This marks the UK as the first European country to host such a study and builds on Neuralink’s earlier human trials in the US, where five paralyzed patients have already used the chip to operate devices mentally. Neuralink’s N1 chip is a small device, about the size of a 10-pence coin, equipped with 128 ultra-thin threads that connect approximately 1,000 electrodes to the brain to read electrical activity and translate it into digital commands. The company